Acyclovir-induced acute renal failure and the importance of an expanding waist line

BMJ Case Reports

Volumn , Issue , 2012, Pages

  Seedat, Ahmed ^a   Winnett, Georgia ^a  

^a BASILDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CEFTRIAXONE; STEROID;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BALANCE IMPAIRMENT; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; ENCEPHALITIS; FALLING; FATIGUE; FOLLOW UP; HUMAN; LUMBAR PUNCTURE; MALE; MENINGITIS; MORBID OBESITY; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 84865328435     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2012-006264     Document Type: Article

References (8)

1. http://www.uptodate.com/contents/crystal-induced-acute-kidney-injury- acute-renal-failure
2. Fleischer R, Johnson M. Acyclovir nephrotoxicity: a case report highlighting the importance of prevention, detection and treatment of acyclovir-induced nephropathy. Case Rep Med 2010;2010. Article ID 602783. Pages 1-3.
3. Clinical Pharmacology Bulletin. Department of clinical pharmacology. Christchurch: Christchurch Hospital, Private Bag 4710, 2008.
4. Han PY, Duffull SB, Kirkpatrick CMJ, et al. Dosing in obesity: a simple solution to a big problem. Clin Pharmacol Ther 2007;82:505-8.
5. De Baerdemaeker LEC, Mortier EP, Struys MMRF. Pharmacokinetics in obese patients. Continuing Education Anaesthesia. Crit Care and Pain 2004;4:152-5.
6. Semchuk WM. RQHR pharmacy services. Medication dosing guidelines in obese adults, 2007. http://www.bnf.org
7. Yee JY, Duffull SB. The effects of body weight on dalteparin pharmacokinetics. A preliminary study. Europ J of Clin Pharmacol 2001;56:293-7.
8. Bauer LA, Edwards WAD, Dellinger EP, et al. Influence of weight on aminoglycoside pharmacokinetics in normal weight and morbidly obese patients. Eur J Pharmacol 1983;24:643-7.